Phase 2, open-label, multicenter study of the efficacy and safety of I

Discussion Board › Forums › Clinical Trials › Phase 2, open-label, multicenter study of the efficacy and safety of I

Viewing 1 post (of 1 total)
  • Author
    Posts
  • May 18, 2017 at 5:43 pm #13355
    gavin
    Moderator

    Phase 2, open-label, multicenter study of the efficacy and safety of INCB054828 in patients (pts) with advanced, metastatic, or surgically unresectable cholangiocarcinoma (CCA) with inadequate response to prior therapy.

    http://abstracts.asco.org/199/AbstView_199_182144.html

    Please note that information regarding clinical trials is being provided for informational purposes only. The Cholangiocarcinoma Foundation does not endorse any specific clinical trial. Please discuss any questions you may have about clinical trials with your healthcare provider.

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.